Hybrid intrastromal corneal ring

• US 6,096,076 A
• Filed: 11/21/1997
• Issued: 08/01/2000
• Est. Priority Date: 08/07/1992
• Status: Expired due to Fees

• Current Assignee: Addition Technology, Inc. (AJL Ophthalmic SA)
• Original Assignee: Thomas A. Silvestrini
• Inventors: Silvestrini, Thomas A.
• Primary Examiner(s): Yu, Mickey
• Assistant Examiner(s): Nguyen, Dinh X.
• Application Number:
  US08/976,378
• Time in Patent Office: 984 Days
• Field of Search: 623/5, 606/107, 606/166, 606/167, 604/890.1, 604/891.1, 604/892.1
• US Class Current: 623/5.12
• CPC Class Codes: A61F 2/147 Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts

Abstract

This invention is an intrastromal corneal ring having at least one outer layer of a physiologically compatible polymer having a low modulus of elasticity, which polymer may be hydratable and may be hydrophilic. The inner portion of the hybrid instrastromal corneal ring may be hollow or may contain one or more physiologically compatible polymers.

Claims

1. An intracorneal implant adapted for implantation within a surgically formed channel in the stroma of a human cornea and configured to alter the shape of the cornea to effect refractive correction of an eye, said implant comprising a ring which comprises at least one outer portion comprising a low elastic modulus, physiologically compatible polymer, an inner portion comprising a physiologically compatible polymer having a high elastic modulus, and a chamber which is fillable, said chamber extending circumferentially along an arc of said ring within walls of said ring.

2. The ring of claim 1 where the chamber is completely filled with a gel or settable polymer.

3. The ring of claim 1 where the chamber is filled with a gel or settable polymer selected from polyHEMA hydrogel, cross-linked collagen, cross-linked hyaluronic acid, siloxane gels, polyvinyl pyrrolidone, and organic-siloxane gels.

4. The ring of claim 3 where the chamber is filled with polyvinyl pyrrolidone.

5. The ring of claim 1 additionally comprising a drug or biologic agent.

6. The ring of claim 5 additionally comprising an antiinflammatory or antithrombogenic.

7. The ring of claim 5 where the drug or biologic agent is selected from dexamethasone, heparin, corticosteroids, antimitotics, antithrombogenic and antiangiogenesis factors.

29. The ring of claim 1 wherein the inner portion comprises a single layer.

30. The ring of claim 29 wherein the outer portion comprises a single layer.

31. The ring of claim 1 wherein said ring is a split ring.

8. An intracorneal ring adapted for implantation within a surgically formed channel in the stroma of a human cornea and configured to alter the shape of the cornea to effect refractive correction of an eye, said ring comprising at least one outer layer comprising an elastomeric, physiologically compatible polymer, at least one inner layer comprising a physiologically compatible polymer having an elastic modulus that is greater in value than the elastic modulus of the elastomeric, physiologically compatible polymer, and a chamber which is fillable, said chamber extending circumferentially along an arc of said ring and surrounded by said outer layer.

9. The ring of claim 8 where the chamber is fillable with a liquid.

10. The ring of claim 8 in which the chamber is completely filled with a settable polymer.

11. The ring of claim 10 where the settable polymer is selected from polyHEMA hydrogel, cross-linked collagen, cross-linked hyaluronic acid, siloxane gels, polyvinyl pyrrolidone, and organic-siloxane gels.

12. The ring of claim 11 where the settable polymer is polyvinyl pyrrolidone.

13. An intracorneal implant adapted for implantation within a human cornea and configured to alter the shape of the cornea to effect refractive correction of an eye, said implant comprising an elongated arcuate member having at least one outer portion of a low elastic modulus, physiologically compatible polymer, an inner portion comprising a physiologically compatible polymer having an elastic modulus that is greater in value than the elastic modulus of the low elastic modulus, physiologically compatible polymer, and a chamber within said implant.

14. The intracorneal implant of claim 13, wherein said elongated arcuate member is a ring.

15. The intracorneal implant of claim 14, wherein said ring is a split ring.

16. The intracorneal implant of claim 15 wherein said split ring has ends, said ends being spaced from one another.

17. The intracorneal implant of claim 16 further comprising a connector situated between said ends.

18. The intracorneal implant of claim 17 wherein said connector has a receiver port.

19. The implant of claim 13 wherein said chamber comprises at least two adjacent chambers separated by baffle walls.

20. The implant of claim 19 wherein at least one of said baffle walls further comprises a hole extending from one of said at least two chambers to an adjacent chamber of said at least two chambers.

27. The implant of claim 13 wherein the outer portion is a layer of the implant.

21. An intracorneal implant adapted for implantation within a human cornea and configured to alter the shape of the cornea to effect refractive correction of an eye, said implant comprising an elongated arcuate member having ends and having at least one outer portion comprising a first polymer having a first elastic modulus, an inner portion comprising a second polymer having a second elastic modulus that differs substantially from the first elastic modulus, and a chamber formed within at least a portion of said inner portion.

22. The implant of claim 21 wherein the first polymer comprises a low elastic modulus polymer.

23. The implant of claim 21 wherein the first polymer comprises a polymer selected from polyhydroxyethyl methacrylate, polyvinylpyrrolidone, crosslinked dextran, crosslinked heparin, hyaluronic acid, latex rubber, colloids of polyester and polyether, polyurethane, polysilicone, isoprene, an interpenetrating network of polymerized vinyl pyrrolidone and methyl methacrylate, polyesters, and polyacrylates.

24. The implant of claim 22 wherein the second polymer comprises a high elastic modulus polymer.

25. The implant of claim 24 wherein the high elastic modulus polymer comprises a polymer selected from PMMA, PTFE, silicone, polycarbonate, a polyolefin selected from polyethylene, polypropylene, polybutylene, and mixtures or interpolymers thereof.

26. The implant of claim 21 additionally comprising a drug or biologic agent.

28. The implant of claim 21 wherein the outer portion is a layer of the implant.